O36.01
Maternal care for anti-D [Rh] antibodies
Clinical Classification Guidelines
Medical Intelligence & Overview
Maternal care for anti-D [Rh] antibodies pertains to the medical management of pregnant women who have developed antibodies against the Rh factor, particularly the D antigen, present on red blood cells. This condition can pose risks to both the mother and the fetus, especially during pregnancy. Proper monitoring and management are essential to prevent complications such as hemolytic disease of the fetus and newborn (HDFN).
Causes & Symptoms
Clinical Causes: Previous pregnancy with an Rh-positive baby Rh-incompatible blood transfusions Maternal sensitization due to obstetric or other medical procedures Early pregnancy loss or abortions in an Rh-negative woman with an Rh-positive fetus
Key Symptoms: Typically no symptoms in the mother Signs of fetal anemia in some cases, such as decreased fetal movements In severe cases, signs of hydrops fetalis, including swelling, skin fluid accumulation, or difficulty breathing in the fetus
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to determine the blood types of both mother and fetus. Specifically, antibody screening (indirect Coombs test) is performed to detect anti-D antibodies in the mother's blood. If antibodies are present, further testing, such as antibody titers, are used to measure the level of sensitization. Fetal monitoring may include ultrasound assessments and, in certain cases, amniocentesis or middle cerebral artery Doppler ultrasound to evaluate fetal wellbeing and assess for anemia.
Treatment Protocols: Management strategies focus on preventing or minimizing fetal complications. These include:
Clinical Advice & FAQs
Billing Guidance
Is O36.01 a billable ICD-10 code?
Yes, O36.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.01?
Clinical documentation must specify the nature of Maternal care for anti-D [Rh] antibodies and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
